{"id":10195,"date":"2019-07-19T10:12:08","date_gmt":"2019-07-19T08:12:08","guid":{"rendered":"https:\/\/udic.es\/?p=10195"},"modified":"2024-02-14T19:44:15","modified_gmt":"2024-02-14T18:44:15","slug":"paralisi-supranuclear-progressiva-psp-una-terapia-innovadora","status":"publish","type":"post","link":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/","title":{"rendered":"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora"},"content":{"rendered":"
Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat d’un antic\u00f2s monoclonal antiTau. Si \u00e9s positiu, participarem en el desenvolupament de l’assaig de fase II per comprovar tamb\u00e9 l’efic\u00e0cia i seguretat de diferents dosis d’aquest f\u00e0rmac.<\/p>\n","protected":false},"excerpt":{"rendered":"
Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat d’un antic\u00f2s monoclonal antiTau. Si \u00e9s positiu, participarem en el desenvolupament de l’assaig de fase II per comprovar tamb\u00e9 l’efic\u00e0cia i seguretat de diferents dosis d’aquest f\u00e0rmac.<\/p>\n","protected":false},"author":4,"featured_media":9250,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[106],"tags":[],"class_list":["post-10195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alzeimer-ca"],"yoast_head":"\n